Ï㽶ÊÓƵ today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger Ï㽶ÊÓƵ (mÏ㽶ÊÓƵ) therapeutics and vaccines, to support two innovative...
Ï㽶ÊÓƵ has joined Moderna’s mÏ㽶ÊÓƵ Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through...